Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT).

Lyttle, Mark D; Bielicki, Julia A; Barratt, Sam; Dunn, David; Finn, Adam; Harper, Lynda; Jackson, Pauline; Powell, Colin VE; Roland, Damian; Stohr, Wolfgang; +9 more... Sturgeon, Kate; Wan, Mandy; Little, Paul; Faust, Saul N; Robotham, Julie; Hay, Alastair D; Gibb, Diana M; Sharland, Mike; PERUKI, GAPRUKI and the CAP-IT trial team; (2019) Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT). BMJ OPEN, 9 (5). e029875-. ISSN 2044-6055 DOI: https://doi.org/10.1136/bmjopen-2019-029875

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1136/bmjopen-2019-029875

Abstract

Share

Download

Filename: Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children wit.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar